CL2008001476A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT; AND ITS USE TO TREAT POST-HERPETIC NEURALGIA. - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT; AND ITS USE TO TREAT POST-HERPETIC NEURALGIA.

Info

Publication number
CL2008001476A1
CL2008001476A1 CL200801476A CL2008001476A CL2008001476A1 CL 2008001476 A1 CL2008001476 A1 CL 2008001476A1 CL 200801476 A CL200801476 A CL 200801476A CL 2008001476 A CL2008001476 A CL 2008001476A CL 2008001476 A1 CL2008001476 A1 CL 2008001476A1
Authority
CL
Chile
Prior art keywords
agent
combination
pharmaceutical composition
herpetic neuralgia
convulsive
Prior art date
Application number
CL200801476A
Other languages
Spanish (es)
Inventor
Armenta Maria Elena San Garcia
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008001476(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of CL2008001476A1 publication Critical patent/CL2008001476A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CL200801476A 2007-05-21 2008-05-20 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT; AND ITS USE TO TREAT POST-HERPETIC NEURALGIA. CL2008001476A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2007006093A MX2007006093A (en) 2007-05-21 2007-05-21 Pharmaceutical composition combining an anticonvulsant agent and an antiviral agent.

Publications (1)

Publication Number Publication Date
CL2008001476A1 true CL2008001476A1 (en) 2008-07-11

Family

ID=40032120

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200801476A CL2008001476A1 (en) 2007-05-21 2008-05-20 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT; AND ITS USE TO TREAT POST-HERPETIC NEURALGIA.

Country Status (7)

Country Link
AR (1) AR066668A1 (en)
CL (1) CL2008001476A1 (en)
CO (1) CO6241103A2 (en)
MX (1) MX2007006093A (en)
PE (1) PE20090292A1 (en)
UY (1) UY31095A1 (en)
WO (1) WO2008143490A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1093366E (en) * 1998-07-09 2005-02-28 Warner Lambert Co PHARMACEUTICAL COMPOSITIONS CONTAINING GABA ANALOGS AND AN ANTIBIRAL AGENT FOR THE TREATMENT OF HERPES ZOSTER

Also Published As

Publication number Publication date
PE20090292A1 (en) 2009-04-04
MX2007006093A (en) 2009-02-25
WO2008143490A1 (en) 2008-11-27
UY31095A1 (en) 2008-11-28
CO6241103A2 (en) 2011-01-20
AR066668A1 (en) 2009-09-02

Similar Documents

Publication Publication Date Title
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
CL2008000063A1 (en) MICROCAPSULA THAT INCLUDES AN AGLOMERATION OF PRIMARY MICROCAPSULES AND A LOAD SUBSTANCE; PREPARATION PROCESS; AND ITS USE TO DELIVER A LOAD SUBSTANCE TO A SUBJECT.
CL2007002021A1 (en) COMPOUNDS DERIVED FROM OXOISOINDOL; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM; AND ITS USE TO TREAT ARRITMIAS.
CL2008000793A1 (en) COMPOUNDS DERIVED FROM DIHYDROINDAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN IRON DISORDER.
CL2013001339A1 (en) Condensed heterocyclic derivative compounds, with antiviral activity; pharmaceutical composition that includes them; and its use for the prevention or treatment of HIV infection.
CL2008000188A1 (en) AGENT TO DELETE THE REACTION OF CHRONIC REJECTION THAT INCLUDES AS AN ACTIVE INGREDIENT AN IL-6 INHIBITOR; AND USE OF THE IL-6 INHIBITOR.
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2008000794A1 (en) COMPOUNDS DERIVED FROM BIARILO AND HETEROARILO; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN IRON DISORDER.
CL2008002319A1 (en) Compounds derived from pyrrolopyrimidine; pharmaceutical composition comprising said compounds; and its use to treat cancer.
CL2007003565A1 (en) COMPOUNDS DERIVED FROM REPLACED PIPERIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN HIV INFECTION.
CL2008000094A1 (en) COMPOUNDS DERIVED FROM PTERIDINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO INCREASE VASODILATATION.
BRPI0815170A2 (en) Pharmaceutical composition comprising an sglt 2 inhibitor
CL2008001334A1 (en) ANTI-MUC16 ANTIBODY DESIGNED WITH CISTEINE; CONJUGADO THAT UNDERSTANDS IT; METHOD OF PRODUCTION; PHARMACEUTICAL FORMULATION THAT UNDERSTANDS IT; AND ITS USE TO TREAT CANCER.
CL2008003712A1 (en) Compounds derived from thiadiazoloxyphenylamidine or thiazolyloxyphenylamidine; its preparation procedure; use and procedure to combat unwanted microorganisms; agent comprising said compounds; intermediate compounds; and its preparation procedure.
CL2011001232A1 (en) Pharmaceutical combination comprising an antibody that specifically recognizes cd38 and at least cytarabine; and its use for cancer treatment
CL2007002971A1 (en) COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS.
CL2011002595A1 (en) Use of a combination of an anticancer agent and an antioxidant to treat cancer; and pharmaceutical composition comprising said combination.
CL2008001835A1 (en) Use of polycyclic guanine derived compounds to treat inflammation; guanine derived compounds; and pharmaceutical composition that includes them.
CL2007002970A1 (en) COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS.
CL2007003232A1 (en) COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.
CL2007003644A1 (en) ANTIPARASITARY COMPOSITION THAT INCLUDES A COMPOSITE DERIVED FROM REPLACED PIRAZOL AND A SECOND ANTIPARASITARY AGENT; KIT THAT UNDERSTANDS IT; AND USE TO TREAT A PARASITARY INFESTATION.
CR10454A (en) LOW-DOSE NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE NIMESULIDE, PREPARATION AND USE OF THE SAME
CL2008000463A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED BENZOFURANS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PARASITARY INFECTIONS.
CL2007003643A1 (en) PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS.
BR112013014189A2 (en) pharmaceutical composition comprising transcinamaldehyde and its use in the treatment of infections